Financial highlights
Consolidated financial figures
| Period | 38th Fiscal Year | 37th Fiscal Year | 36th Fiscal Year | 35th Fiscal Year | 34th Fiscal Year |
|---|---|---|---|---|---|
| Fiscal Year | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
| Net Sales(In-house Research & Development Staff on Science)(million yen) | 47,602 (32,173) |
46,875 (31,523) |
44,126 (30,487) |
43,108 (29,836) |
41,569 (28,669) |
| Gross Margin(million yen) | 11,934 | 12,492 | 11,533 | 11,381 | 10,615 |
| Operating Income(million yen) | |||||
| Ordinary Income(million yen) | 5,614 | 6,393 | 5,243 | 4,961 | 4,989 |
| Ordinary Income Rate(%) | 11.8 | 13.6 | 11.9 | 11.5 | 12.0 |
| Net Income Attributable to Owners of The Parent Company(million yen) | 3,540 | 4,171 | 3,405 | 3,114 | 2,922 |
| Net Assets Amount(million yen) | 28,463 | 25,796 | 22,302 | 19,687 | 16,273 |
| Total Assets(million yen) | 36,198 | 33,828 | 30,619 | 26,545 | 23,462 |
| Operating Cash Flow(million yen) | 3,553 | 4,025 | 4,202 | 3,043 | 3,322 |
| Investment Cash Flow(million yen) | - 337 | - 6,104 | - 122 | - 531 | - 432 |
| Financial Cash Flow(million yen) | - 1,307 | - 870 | - 901 | 428 | - 388 |
| Capital to Asset Ratio(%) | 76.3 | 74.2 | 71.2 | 72.8 | 69.4 |
| ROE (Return on Equity)(%) | 13.4 | 17.8 | 16.6 | 17.5 | 19.4 |
| ROA (Return on Assets)(%) | 10.1 | 12.9 | 11.9 | 12.5 | 13.3 |
| Closing Market Price(yen) | 1,986 | 2,716 | 2,594 | 2,107 | 3,090 |
| BPS (Net Assets / 1 Share)(million yen) | 1,405.7 | 1,272.3 | 1,105.1 | 974.4 | 820.3 |
| P/B (Price Book-value Ratio) | 1.4 | 2.1 | 2.3 | 2.2 | 3.7 |
| Market Capitalization(million yen) | 39,839 | 54,483 | 52,036 | 42,266 | 61,985 |
| EPS (Current Net Income / 1 Share)(yen) | 179.7 | 211.3 | 171.8 | 157.0 | 147.3 |
| P/E (Price Earnings Ratio) | 11.0 | 12.9 | 15.1 | 13.4 | 20.9 |
| Dividend / 1 Share(yen) | 51.5 | 49.5 | 37.5 | 27.5 | 22.5 |
| Dividend / Total(million yen) | 1,013 | 976 | 744 | 546 | 446 |
| Dividend Payout Ratio(%) | 28.7 | 23.4 | 21.8 | 17.5 | 15.3 |
| Dividend Yield(%) | 2.6 | 1.8 | 1.4 | 1.3 | 0.7 |
| DOE (Dividend on Equity Ratio)(%) | 3.8 | 4.2 | 3.6 | 3.1 | 3.0 |
Net Sales
Net Sales
R&D Staff on Science
Gross Margin
Gross Margin
Gross Profit Margin
Operating Income
Operating Income
Operating Income Rate
Ordinary Income
Ordinary Income
Ordinary Income Rate
Net Income Attributable to Owners of The Parent Company
Net Income Attributable to Owners of The Parent Company
Net Profit Margin
ROE (Return on Equity), ROA (Return on Assets)
ROE (Return on Equity)
ROA (Return on Assets)
Capital to Asset Ratio
Capital to Asset Ratio
Total Assets
Total Assets
Net Assets Amount
Net Assets Amount
BPS (Net Assets / 1 Share),EPS (Current Net Income / 1 Share)
BPS (Net Assets / 1 Share)
EPS (Current Net Income / 1 Share)
P/E (Price Earnings Ratio),P/B (Price Book-value Ratio)
P/E (Price Earnings Ratio)
P/B (Price Book-value Ratio)
※YE：Year-End
Dividend / 1 Share
Mid-term
Term-end
※ *：Forecast
Dividend / Total
Dividend / Total
※ *：Forecast
Dividend Payout Ratio, Dividend Yield
Dividend Payout Ratio
Dividend Yield
※ *：Forecast
Market Capitalization, Closing Market Price
Market Capitalization
Closing Market Price
※YE：Year-End
DOE (Dividend on Equity Ratio)
DOE (Dividend on Equity Ratio)
Various Indicators from Listing (2006) to The Present
Market Capitalization, Stock Price, PER (Price Earnings Ratio)
Market Capitalization
Stock Price
PER (Price Earnings Ratio)
Please refer to the following page for further information, click here (price information page on Yahoo Finance).
Actual results against projected figures
| Period | 39th Fiscal Year | 38th Fiscal Year | 37th Fiscal Year | 36th Fiscal Year | 35th Fiscal Year |
|---|---|---|---|---|---|
| Projections Announced | 2023 May 12 | 2022 May 13 | 2021 May 14 | 2020 May 14 | 2019 May 10 |
Net Sales
Plan
Result
Achievement Rate
Gross Margin
Plan
Result
Achievement Rate
Ordinary Income
Plan
Result
Achievement Rate
Net Income Attributable to Owners of the Parent Company
Plan
Result
Achievement Rate